[Calcium sensitizer: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Shinagawa
Hisahito
H
Department of Cardio-angiology, Kitasato University School of Medicine.
Izumi
Tohru
T
D002118:Calcium / Q000378:metabolism*; D002316:Cardiotonic Agents; D002986:Clinical Trials as Topic; D000075202:Contraindications; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D000077464:Simendan; D013268:Stimulation, Chemical; D015996:Survival Rate
D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan; C041648:pimobendan; D002118:Calcium